Soft-Launch definition

Soft-Launch means the first day on which the Managed Services are to be provided to You, as agreed between the parties and commercial billing periods commence. Also referred to as the “Effective Date”
Sample 1Sample 2Sample 3
Soft-Launch means Bullish Exchange’s initial launch stage using real assets with select institutional customers on an invite-only basis.
Sample 1Sample 2Sample 3
Soft-Launch means, as applicable with respect to a Switch Service Area or System, the commencement of the Trial Run after the Provisional Acceptance (or Partial Provisional Acceptance) of such Switch Service Area or System, as the case may be.
Sample 1Sample 2

Examples of Soft-Launch in a sentence

  • Upon completion of the UAT, TripSpark and the Licensee will mutually agree upon a Soft Launch Go-Live date.

  • The Soft Launch shall be a mandatory even for the Concessionaire to avail the Completion Certificate.

  • The subscription term (the “Term”) begins on Customer’s Soft Launch (as herein defined) Date or 120 days from signature date on Quote, whichever comes first, and continues for duration of Term set forth in executed Quote.

  • Upon completion of Construction Works, the Independent Engineer determining the Tests to be successful and upon successful Soft Launch, the Independent Engineer shall forthwith issue to the Concessionaire and the Authority a certificate substantially in the form set forth in Schedule-I (the “Completion Certificate”).

  • Full Launch Go-Live Upon completion of Soft Launch for Notifications, Licensee can now enroll all passengers at its discretion.

  • Full Launch Go-Live Upon completion of Soft Launch, the Licensee can now invite all passengers to enroll and access the site.

  • Soft Launch (“Soft Launch”) is the first day Customer’s incident data is available in the production environment.

  • Go-Live Support Soft Launch Go-Live Before releasing the Passenger Portal for all passengers, TripSpark recommends asking a select group of passengers to test the website and assist with an additional round of troubleshooting.

  • Go-Live Support Soft Launch Go-Live Licensee should enroll an ideal sample population of passengers in Notifications for a pilot run.

  • BACKPAGE / LIBRARY MODERNIZATION JULY 2016 6 AIT Library Soft Launch for the August 2016 Semester: A Snapshot of the Progress of the AIT Library Modernization.


More Definitions of Soft-Launch

Soft-Launch means operation of the 311 Contact Centre by routing some or all of the calls from the existing call centres, before the formal publicized 311 Contact Centre launch;
Sample 1
Soft-Launch means that the Marketplace satisfies at least the following criteria:
Sample 1
Soft-Launch means the test to be performed under article 4 and as described in Appendix 3 and the period in which ELEPHANT TALK can gain experience with the functionalities of the Hosting Services prior to the Commercial Launch Date. CONFIDENTIAL TREATMENT REQUESTED WITH RESPECT TO CERTAIN PORTIONS HEREOF DENOTED WITH “***” Hosting Agreement between ELEPHANT TALK and T-Mobile, 18/9/2008
Sample 1
Soft-Launch has the meaning set forth in Clause 7.2.
Sample 1
Soft-Launch means where Supplier commences the field work by sending the Survey to 10%-20% of the total Respondents and then undertakes an analysis of the data in order to check if there is a perfect match with Client expectations. Services means the services to be performed by Supplier as described in the Proposal. If Client elects under a Work Order to procure Toluna QuickSurveys, then it shall comply with the terms found at: xxxxx://xxx.xxxxxxxxxxxx.xxx/Content/Policies/Terms-and-Conditions.aspx (“TQS Terms”). If there is any conflict between the TQS Terms and the terms of this Agreement, the terms of this Agreement shall prevail.
Sample 1
Soft-Launch means that it will be visible only to folks on the CCOM network. The website team has worked long and hard to reach this point and are very excited to share their work with everyone.
Sample 1

Related to Soft-Launch

  • Commercial Launch means on a country-by-country basis, the first sale of a Product to a Third Party following Regulatory Approval of the Product in such country.

  • Launch means the intentional ignition of the first-stage motor(s) of the Launch Vehicle intended to place or try to place a Launch Vehicle (which may or may not include any Transfer Vehicle, Payload or crew) from Earth:

  • Launch Date has the meaning specified therefor in Section 2.02(b) of this Agreement.

  • Programme Date means the date of this Base Prospectus.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • System Impact Study means an assessment by the Transmission Provider of (i) the adequacy of the Transmission System to accommodate a Completed Application, an Interconnection Request or an Upgrade Request, (ii) whether any additional costs may be incurred in order to provide such transmission service or to accommodate an Interconnection Request, and (iii) with respect to an Interconnection Request, an estimated date that an Interconnection Customer’s Customer Facility can be interconnected with the Transmission System and an estimate of the Interconnection Customer’s cost responsibility for the interconnection; and (iv) with respect to an Upgrade Request, the estimated cost of the requested system upgrades or expansion, or of the cost of the system upgrades or expansion, necessary to provide the requested incremental rights. System Protection Facilities: “System Protection Facilities” shall refer to the equipment required to protect (i) the Transmission System, other delivery systems and/or other generating systems connected to the Transmission System from faults or other electrical disturbance occurring at or on the Customer Facility, and (ii) the Customer Facility from faults or other electrical system disturbance occurring on the Transmission System or on other delivery systems and/or other generating systems to which the Transmission System is directly or indirectly connected. System Protection Facilities shall include such protective and regulating devices as are identified in the Applicable Technical Requirements and Standards or that are required by Applicable Laws and Regulations or other Applicable Standards, or as are otherwise necessary to protect personnel and equipment and to minimize deleterious effects to the Transmission System arising from the Customer Facility. Transmission Facilities:

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Product Schedule means PTC’s standard order form entitled “PTC Product Schedule” (including all schedules, attachments and other document(s) specifically referenced therein) or such alternative order form as may be submitted by Customer and accepted by PTC, in each case that specifies (i) the Licensed Products and/or Services ordered; and (ii) for Licensed Products, the installation address (including the Designated Country) and the Licence Term.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Commercial Software means Software developed or regularly used that: (i) has been sold, leased, or licensed to the general public; (ii) has been offered for sale, lease, or license to the general public; (iii) has not been offered, sold, leased, or licensed to the public but will be available for commercial sale, lease, or license in time to satisfy the delivery requirements of this Contract; or (iv) satisfies a criterion expressed in (i), (ii), or (iii) above and would require only minor modifications to meet the requirements of this Contract.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Commercialization Plan has the meaning set forth in Section 6.2.

  • Non-Microsoft Product means any third-party-branded software, data, service, website or product, unless incorporated by Microsoft in a Product.

  • Programme of work means the Programme of work submitted by the contractor and approved by the Engineer-in-charge and includes and amendment thereto made from time to time and approved by the Engineer-in-charge;

  • Program Period means the period of time which the department intends to support the program without requiring the recompetition for funds. The program period is specified within the grant application.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Program change means any elimination, curtailment or reorganization of a curriculum offering, program or school operation or a reorganization or closing of a school or consolidation of two or more individual schools or school districts that is unrelated to financial exigency.

  • service delivery and budget implementation plan means a detailed plan approved by the executive mayor of a municipality in terms of section 53(l)(c)(ii) of the MFMA for implementing the municipality's delivery of municipal services and its annual budget, and which must indicate

  • Program of study means a curriculum that requires a candidate to demonstrate and document competency in the specific knowledge, skills, and dispositions for a particular endorsement to an educator’s license, a licensure content area, or level of licensure, and is: